Da'an Pharmaceutical

Yuanda Medical Nutrition Science (Wuhan) Co., Ltd. is a subsidiary of the life sciences sector of China Yuanda Group, a national high-tech enterprise and a specialized, refined, distinctive and innovative "Little Giant" enterprise in Hubei Province. With innovation as its source of momentum and a solid industrial foundation as its support, the company focuses on the research, development and industrialization of parenteral and enteral nutrition and novel-mechanism nutritional drugs, and is committed to providing patients with medical nutrition solutions covering the full life cycle through technological innovation. Relying on a high-end formulation platform and core patented technologies, the company has undertaken more than ten national, provincial and municipal key R&D and industrialization projects, including the National Torch Plan, the National Major Science and Technology Project for "Major New Drug Creation", and the National Innovation Fund for Small and Medium-sized Enterprises, and has won multiple honors such as "National Demonstration Academician Expert Workstation", "Outstanding Enterprise of China Innovation and Entrepreneurship Competition", and "Hubei Province Enterprise Science and Technology Innovation Award". Its independently developed products such as "Anfu®" and "Litai®" have twice won the second prize and twice won the third prize of the Hubei Provincial Science and Technology Progress Award, fully demonstrating its capacity for continuous innovation and achievement transformation. The company always adheres to the philosophy of "research-based, patient-centered", closely tracks global diagnostic and treatment trends and unmet clinical needs, and proactively builds a distinctive product matrix. Around the three major health challenges of "population aging, chronic diseaseization of tumors, and precision treatment", it is striving to build an innovative pipeline layout with amino acids as the core, parenteral and enteral nutrition as the main body, and full-cycle nutrition management as an extension. At present, it has completed the development of more than ten new products including children's nutrition, elderly nutrition, and tumor nutrition. In industrial manufacturing, the company adheres to the product policy of "life first, quality-oriented, innovative development, continuous improvement", practices the concept of full life cycle management, comprehensively benchmarks against international standards such as ICH, WHO, EMA and PIC/S, and has built a highly integrated quality management system. The company has a comprehensive cluster of parenteral and enteral nutrition production lines, has passed official inspections at all levels in one go every year, and the qualified rate of products in market spot checks has remained 100% for many consecutive years. Talent is the core engine of high-quality development. The company attaches great importance to talent echelon construction and deep integration of industry, academia and research. More than 72% of its R&D team holds a master's degree or above, and many have been selected for provincial and municipal high-level talent programs such as "Huanghe Yingcai" and "Wuhan Yingcai". As a teaching and internship base and a joint master's and doctoral training unit for well-known universities such as Huazhong University of Science and Technology and Wuhan University, the company continues to attract and cultivate interdisciplinary pharmaceutical talent. At the same time, it provides employees with diversified career development channels, a comprehensive welfare guarantee system and rich cultural and sports activities, and is committed to creating a professional, rigorous, growth-oriented and vibrant working environment. Looking to the future, Yuanda Medical Nutrition will continue to deepen the trinity development strategy of "innovation + manufacturing + talent", contributing scientific and technological strength to "Healthy China".